Gut-friendly psychobiotics could brighten moods and fight depression

FHS
April 8, 2024
4:37 am

Review uncovers that psychobiotics may offer supportive treatment for depression by restoring gut microbiome balance and positively influencing the microbiome-gut-brain axis, which is crucial for mental health and well-being.

Roche begins Phase 2 obesity trial for GLP-1/GIP agonist, striking while iron is hot

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 31, 2024

House Committee Wrestles With Lab Test Regulation

Members of a House committee mostly agreed that laboratory-developed tests need more oversight, but were divided Thursday on how best to approach the topic. The

March 22, 2024

CHMP recommends against Mirati’s KRAS rival, in favor of Pfizer’s RSV vaccine, other drugs

The European Medicines Agency’s human medicines committee (CHMP) recommended against conditional authorization for Mirati’s KRAS G12C inhibitor Krazati in non-small cell lung cancer this week,

July 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.